As of March 23, 2026, Corcept Therapeutics's top three insider holders are Joseph K Belanoff (Chief Executive Officer, 2.94Mn shares), David L Mahoney (Director, 1.21Mn shares), James N Wilson (Director, 1.13Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| David L Mahoney | 0 | 1,237,145 | 17 Mar, 2026 | |
| G Leonard Jr Baker | 1,146,631 | 0 | 19 Mar, 2026 | |
| James N Wilson | 0 | 1,106,532 | 17 Mar, 2026 | |
| G Leonard Jr Baker | 0 | 1,095,262 | 29 Jan, 2026 | |
| Hazel Hunt | Chief Scientific Officer | 255,437 | 0 | 11 Feb, 2026 |
| Gary Charles Robb | Chief Business Officer | 79,503 | 0 | 04 Mar, 2026 |
| Sean Maduck | See Remarks | 0 | 34,000 | 13 Feb, 2026 |
| Atabak Mokari | Chief Financial Officer | 15,257 | 0 | 04 Mar, 2026 |
| Gary Charles Robb | Chief Business Officer | 0 | 11,571 | 22 May, 2025 |
| Joseph Douglas Lyon | See Remarks | 11,230 | 0 | 04 Mar, 2026 |
| Sean Maduck | See Remarks | 8,977 | 0 | 04 Mar, 2026 |
| William Guyer | Chief Development Officer | 2,231 | 0 | 06 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | G Leonard Jr Baker | Common Stock | A | 75,782 | $33.00 | 1,122,413 | D | P |
| 17 Mar, 2026 | G Leonard Jr Baker | Common Stock | A | 24,218 | $33.56 | 1,146,631 | D | P |
| 13 Mar, 2026 | James N Wilson | Common Stock | D | 28,000 | $0.00 | 1,106,532 | I | G |
| 13 Mar, 2026 | David L Mahoney | Common Stock | A | 30,000 | $5.86 | 30,000 | D | M |
| 13 Mar, 2026 | David L Mahoney | Common Stock | D | 5,469 | $32.15 | 24,531 | D | F |
| 13 Mar, 2026 | David L Mahoney | Common Stock | D | 24,531 | $0.00 | 0 | D | G |
| 13 Mar, 2026 | David L Mahoney | Common Stock | A | 24,531 | $0.00 | 1,237,145 | I | J |
| 13 Mar, 2026 | David L Mahoney | Stock Option (right to buy) | D | 30,000 | $0.00 | 0 | D | M |
| 04 Mar, 2026 | William Guyer | Common Stock | A | 8,233 | $21.65 | 10,464 | D | M |
| 04 Mar, 2026 | William Guyer | Common Stock | D | 8,233 | $35.99 | 2,231 | D | S |
| 04 Mar, 2026 | William Guyer | Stock Option (right to buy) | D | 8,233 | $0.00 | 221,767 | D | M |
| 02 Mar, 2026 | Sean Maduck | Common Stock | A | 454 | $35.97 | 8,633 | D | A |
| 02 Mar, 2026 | Joseph Douglas Lyon | Common Stock | A | 398 | $35.97 | 10,921 | D | A |
| 02 Mar, 2026 | Atabak Mokari | Common Stock | A | 397 | $35.97 | 14,956 | D | A |
| 02 Mar, 2026 | Gary Charles Robb | Common Stock | A | 499 | $35.97 | 79,125 | D | A |
| 02 Mar, 2026 | William Guyer | Common Stock | A | 498 | $35.97 | 1,733 | D | A |
| 02 Mar, 2026 | Joseph Douglas Lyon | Common Stock | A | 398 | $0.00 | 11,319 | D | A |
| 02 Mar, 2026 | Gary Charles Robb | Common Stock | A | 499 | $0.00 | 79,624 | D | A |
| 02 Mar, 2026 | Sean Maduck | Common Stock | A | 454 | $0.00 | 9,087 | D | A |
| 02 Mar, 2026 | Atabak Mokari | Common Stock | A | 397 | $0.00 | 15,353 | D | A |